Image

Association Between 4D MRI Parameters and the Clinical Characteristics and Prognosis of Major Chronic Diseases

Association Between 4D MRI Parameters and the Clinical Characteristics and Prognosis of Major Chronic Diseases

Recruiting
19 years and older
All
Phase N/A

Powered by AI

Overview

Cancer and cardiovascular diseases are among the leading causes of morbidity and mortality worldwide. Advanced imaging techniques such as 4D magnetic resonance imaging (MRI) enable quantitative assessment of hemodynamic and functional parameters beyond conventional imaging. The aim of this study is to evaluate the association between 4D MRI derived parameters and the occurrence, severity, and prognosis of major chronic diseases, and to explore their potential role as imaging biomarkers.

Description

This is a single-center, prospective, observational registry study conducted at Ulsan University Hospital. The study will enroll 1,000 adult patients (≥ 19 years) undergoing cardiac MRI as part of routine clinical care in Korea.

Participants will undergo an additional 4D MRI sequence during the same imaging session, which does not affect clinical decision-making or patient management.

The primary objective of this study is to evaluate the association between quantitative imaging parameters derived from 4D MRI and the occurrence, severity, and prognosis of major chronic diseases.

Eligibility

Inclusion Criteria:

  • Adults aged 19 years and older undergoing clinically indicated Cardiac MRI at Ulsan University Hospital
  • Participants who undergo an additional 4D MRI sequence during the same imaging session
  • Participants who are able to understand the study and provide written informed consent

Exclusion Criteria:

  • Individuals aged \< 19 years
  • Individuals with cognitive impairment or communication difficulties unable to provide informed consent
  • Poor-quality MRI images that are not suitable for analysis
  • Individuals deemed inappropriate for study participation by the investigator

Study details
    Cardiovascular Disease
    Cardiac Magnetic Resonance Imaging
    Neoplasm

NCT07678606

Ulsan University Hospital

20 October 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.